264 related articles for article (PubMed ID: 26251734)
1. The role of epigenetics in kidney malignancies.
la Rosa AH; Acker M; Swain S; Manoharan M
Cent European J Urol; 2015; 68(2):157-64. PubMed ID: 26251734
[TBL] [Abstract][Full Text] [Related]
2. Epigenetics application in the diagnosis and treatment of bladder cancer.
Harb-de la Rosa A; Acker M; Kumar RA; Manoharan M
Can J Urol; 2015 Oct; 22(5):7947-51. PubMed ID: 26432963
[TBL] [Abstract][Full Text] [Related]
3. Current Concepts of Epigenetics in Testicular Cancer.
la Rosa AH; Manoharan M; Goolam AS
Indian J Surg Oncol; 2017 Jun; 8(2):169-174. PubMed ID: 28546713
[TBL] [Abstract][Full Text] [Related]
4. Genetics and epigenetics of renal cell cancer.
Baldewijns MM; van Vlodrop IJ; Schouten LJ; Soetekouw PM; de Bruïne AP; van Engeland M
Biochim Biophys Acta; 2008 Apr; 1785(2):133-55. PubMed ID: 18187049
[TBL] [Abstract][Full Text] [Related]
5. The epigenetics of renal cell tumors: from biology to biomarkers.
Henrique R; Luís AS; Jerónimo C
Front Genet; 2012; 3():94. PubMed ID: 22666228
[TBL] [Abstract][Full Text] [Related]
6. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
7. Epigenetics in prostate cancer: biologic and clinical relevance.
Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
[TBL] [Abstract][Full Text] [Related]
8. Epigenetics: The Key to Future Diagnostics and Therapeutics of Lung Cancer.
Jha G; Azhar S; Rashid U; Khalaf H; Alhalabi N; Ravindran D; Ahmad R
Cureus; 2021 Nov; 13(11):e19770. PubMed ID: 34820248
[TBL] [Abstract][Full Text] [Related]
9. Epigenetics in renal cell cancer: mechanisms and clinical applications.
Joosten SC; Smits KM; Aarts MJ; Melotte V; Koch A; Tjan-Heijnen VC; van Engeland M
Nat Rev Urol; 2018 Jul; 15(7):430-451. PubMed ID: 29867106
[TBL] [Abstract][Full Text] [Related]
10. Molecular Mechanisms of Epigenetic Regulators as Activatable Targets in Cancer Theranostics.
Li Y; Li Z; Zhu WG
Curr Med Chem; 2019; 26(8):1328-1350. PubMed ID: 28933282
[TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer: epigenetics, drug resistance, and progression.
Xie W; Sun H; Li X; Lin F; Wang Z; Wang X
Cancer Cell Int; 2021 Aug; 21(1):434. PubMed ID: 34404407
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress-induced epigenetic changes associated with malignant transformation of human kidney epithelial cells.
Mahalingaiah PK; Ponnusamy L; Singh KP
Oncotarget; 2017 Feb; 8(7):11127-11143. PubMed ID: 27655674
[TBL] [Abstract][Full Text] [Related]
13. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
14. Epigenetics in Health and Disease.
Zhang L; Lu Q; Chang C
Adv Exp Med Biol; 2020; 1253():3-55. PubMed ID: 32445090
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Alterations in Renal Cell Cancer With TKIs Resistance: From Mechanisms to Clinical Applications.
Li Q; Zhang Z; Fan Y; Zhang Q
Front Genet; 2020; 11():562868. PubMed ID: 33510766
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic modifications in prostate cancer.
Ngollo M; Dagdemir A; Karsli-Ceppioglu S; Judes G; Pajon A; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon DJ
Epigenomics; 2014; 6(4):415-26. PubMed ID: 25333850
[TBL] [Abstract][Full Text] [Related]
17. Insights into novel emerging epigenetic drugs in myeloid malignancies.
Chandhok NS; Prebet T
Ther Adv Hematol; 2019; 10():2040620719866081. PubMed ID: 31431820
[TBL] [Abstract][Full Text] [Related]
18. Epigenetics in prostate cancer: clinical implications.
Conteduca V; Hess J; Yamada Y; Ku SY; Beltran H
Transl Androl Urol; 2021 Jul; 10(7):3104-3116. PubMed ID: 34430414
[TBL] [Abstract][Full Text] [Related]
19. Diabetic nephropathy: The regulatory interplay between epigenetics and microRNAs.
Sankrityayan H; Kulkarni YA; Gaikwad AB
Pharmacol Res; 2019 Mar; 141():574-585. PubMed ID: 30695734
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation and histone modifications as epigenetic regulation in prostate cancer (Review).
Nowacka-Zawisza M; Wiśnik E
Oncol Rep; 2017 Nov; 38(5):2587-2596. PubMed ID: 29048620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]